Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
99 studies found for:    Open Studies | Interventional Studies | "Kidney Failure, Chronic" | United States
Show Display Options
Rank Status Study
1 Recruiting 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
Conditions: Anemia;   End Stage Renal Disease
Intervention: Drug: AKB-6548
2 Recruiting Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
Conditions: End Stage Renal Disease;   Kidney Disease;   Protein Energy Wasting
Interventions: Drug: PINTA 745;   Drug: Placebo
3 Recruiting Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
Conditions: Kidney Failure, Chronic;   End Stage Renal Disease, Requiring Dialysis
Intervention: Device: NxStage System One
4 Recruiting iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
Conditions: End-Stage Kidney Disease;   Kidney Failure, Chronic;   Kidney Transplantation
Intervention: Behavioral: iChoose Kidney Decision Aid
5 Recruiting Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis;   Severe Renal Impairment;   End-stage Renal Disease
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: Ribavirin
6 Recruiting Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Multiple Myeloma and Renal Disease
Conditions: Relapsed Multiple Myeloma;   End-stage Renal Disease
Intervention: Drug: Carfilzomib
7 Recruiting Improving Communication About Serious Illness
Conditions: Critical Illness;   Chronic Disease;   Terminal Care;   Palliative Care;   Communication;   Advance Care Planning;   Neoplasm Metastasis;   Lung Neoplasms;   Pulmonary Disease, Chronic Obstructive;   Heart Failure;   End Stage Liver Disease;   Kidney Failure, Chronic
Intervention: Behavioral: Communication Feedback Form for Patients with Serious Illness
8 Recruiting Choice Sets for Advance Directives
Condition: End Stage Renal Disease
Interventions: Behavioral: Expanded AD Choice;   Behavioral: Expanded Life-sustaining Therapy Choice
9 Not yet recruiting Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
Condition: End-Stage Renal Disease
Intervention: Drug: Spironolactone
10 Recruiting A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
Condition: Anemia
Interventions: Biological: Sotatercept;   Biological: Placebo
11 Recruiting Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Condition: End Stage Renal Disease
Intervention: Device: REVEAL Insertable Cardiac Monitor (ICM)
12 Not yet recruiting L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
Conditions: End Stage Renal Disease;   Hemodialysis
Interventions: Drug: Spironolactone;   Dietary Supplement: L-arginine;   Drug: Placebo
13 Recruiting A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
Conditions: End-Stage Renal Disease;   Secondary Hyperparathyroidism
Intervention: Drug: paricalcitol
14 Recruiting Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Conditions: End Stage Renal Disease (ESRD);   Chronic Kidney Disease (CKD);   Hemodialysis;   Renal Replacement Therapy;   Renal Transplantation
Interventions: Biological: Induction therapy;   Drug: Corticosteroids;   Drug: EVR+rCNI;   Drug: MPA+sCNI
15 Recruiting Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients
Condition: End Stage Renal Disease
Interventions: Device: GORE® Hybrid Vascular Graft;   Device: Non-heparin bonded synthetic graft
16 Recruiting Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation
Conditions: End-Stage Renal Disease;   Kidney Failure;   Kidney Transplantation
Interventions: Drug: Anti-thymocyte Globulin (rabbit) (rATG) (Thymoglobulin);   Drug: Divided-dose Thymoglobulin administration
17 Recruiting A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration
Condition: End Stage Renal Disease
Intervention: Other: Dialysis session of at least 4.25 hours
18 Not yet recruiting Primary Care eHealth Intervention for Improved Outcomes in Chronic Kidney Disease
Conditions: Renal Insufficiency, Chronic;   Kidney Failure, Chronic
Intervention: Other: eHealth Intervention
19 Unknown  A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia
Conditions: End-Stage Renal Disease;   Hemodialysis Catheter-Associated Infection
Intervention: Drug: catheter lock solution consisting of N-acetylcystein, tigecycline and heparin
20 Recruiting Propaten Randomized Investigation on Cost-benefit and Efficacy
Condition: End-stage Renal Disease
Interventions: Device: Heparin-bonded vascular access graft;   Device: Conventional ePTFE hemodialysis graft

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years